How I treat Logo
howitreat.in

Summarized international guidelines and protocols for Indian patients.

A ready reckoner for day today work in ward, casualty, ICU and OPD.

Hypersplenism

Introduction:

  • It is occurrence of one or more cytopenias in the setting of splenomegaly.

 

Etiology:

  • All the causes of splenomegaly can lead to hypersplenism
  • Refer to causes of splenomegaly in the approach to diagnosis section

 

Pathogenesis:

Increased size of filtering bed due to splenomegaly

↓

Increased proportion of blood is channeled through the red pulp

↓

Increased margination of neutrophil pool

Increased sequestration of platelets

Increased clearance of RBCs

Cytopenias can also be due to diseases that cause splenomegaly

 

Clinical Features:

  • Sagging feeling/ abdominal discomfort
  • Early satiety due to gastric encroachment
  • Trouble in sleeping on one side
  • Splenomegaly

 

Investigations:

  • Hemogram- Anemia, neutropenia, thrombocytopenia
  • USG- Splenomegaly

 

Criteria for Diagnosis:

  • Tropical splenomegaly: Splenomegaly of more than 10cm below costal margin with no other cause identified.
  • Sometimes it responds to treatment with antimalarials (Chloroquine), which have to be given for months.

 

Treatment:

  • Depends on the cause
  • Splenectomy is useful in some cases, but generally avoided.
  • Splenic irradiation
  • TPO agonists may be helpful
    • Eltrombopag is associated with high risk of portal vein thrombosis. Hence it must be used with caution.
    • Avatrombopag is approved for use in chronic liver disease

 

Home

About Us

How I treat Logo
howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.